Scott Newbrough, MD
Plastic and Reconstructive Surgery · Tulsa, OKNPI 1053551234
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,556 of the $3,940 with a category attached, or 64.9%. AbbVie accounts for 65.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $2,233 and has fallen 86.5% since, to $301 in 2025.
Across 68 payments — averaging $57.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Polynovo North America LLC$241
- Sientra, Inc.$239
- Davol Inc.$224
- Baxter Healthcare$181
- Smith+Nephew$109
- plus $361 from 12 others
What the payments were for
- Travel & lodging$1,38535%
- Food & beverage$2,55665%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $2,586 |
| Polynovo North America LLC | 6 | $241 |
| Sientra, Inc. | 5 | $239 |
| Davol Inc. | 12 | $224 |
| Baxter Healthcare | 5 | $181 |
| Smith+Nephew | 6 | $109 |
| Vertex | 3 | $85 |
| Acera Surgical, Inc. | 2 | $54 |
| AstraZeneca | 2 | $45 |
| W. L. Gore & Associates, Inc. | 1 | $30 |
| Avita Medical Americas, LLC | 1 | $24 |
| Coopersurgical, Inc. | 1 | $24 |
| Access Pro Medical, LLC | 1 | $22 |
| TELA Bio, Inc. | 2 | $20 |
| Molli Surgical (US) Inc | 1 | $16 |
| Biocomposites Inc | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,940 in reported general payments places this provider in the 55th percentile of 22 plastic and reconstructive surgery providers in Oklahoma.
See all plastic and reconstructive surgery providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $765 |
| Cyclobenzaprine Hcl | 51 | $237 |
| Cephalexin | 42 | $205 |
| Ondansetron Hcl | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Tulsa
- Archibald MillerTulsa$415K
- Stephen PaulsenTulsa$27K
- Greg RatliffTulsa$13K
- Angie HigniteTulsa$4K
- Shaw TangTulsa$3K
- Laurie DuckettTulsa$3K
- Scott KreitzbergTulsa$3K
- Brent RubisTulsa$2K
- Brenda SchieselTulsa$2K
- John TedescoTulsa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.